Clinical trial NCT06760312: Effect of Different Apical Actions on Local Inflammatory Mediators and Pain
Official title: Effect of Different Apical Actions on Local Inflammatory Mediators and Pain During Root Canal Preparation: A Randomized Clinical Study
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Postoperative Dental Pain
Pulp Disease, Dental
Pulpitis - Irreversible
Keywords: apical kinematics
apical action
apical reverse
apical slow-down
continuous rotation
Substance P
postoperative pain
Inflammation
Lead sponsor: Izmir Katip Celebi University
Sponsor class: OTHER
First posted: 2025-01-06
Enrollment: 66
Sex: ALL
Minimum age (years): 18
Maximum age (years): 49
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: n=66 participants will be randomized into 3 different intervention groups.
Primary purpose: TREATMENT

Brief summary: The goal of this clinical trial is to determine patients' the inflammation and pain response to different apical actions used in rotary instrumentation during root canal shaping process. The main questions it aims to answer are:

1. How the different apical actions of endodontic motors influence the pain and inflammatory mediator release from the periapical region of related tooth?
2. Does the perceived pain differ among the used apical action methods after the root canal preparation?
3. Are the perceived pain and local pain mediator levels coherent?

Participants will:

Attend to the root canal treatment in the endodontics clinic. The treatment will be two visits.

Answer the Visual Analog Scale questionnaire on day 0 (first appt.) and Day 3 (second appt.) Keep a diary of their symptoms and the number of times they use an anti-inflammatory drug.

Detailed description: Study Protocol

This study will include patients aged 18-49 years who present to the İzmir Katip Çelebi University, Department of Endodontics, requiring root canal treatment for vital, lesion-free mandibular first and second molars. Patients with systemic diseases will be excluded. The study will involve 66 patients. The sample size was calculated according to the effect size of 0,25 recommended by Cohen (1988).

Pre-Treatment Assessment:

* Patients will be asked about spontaneous pain and percussion pain related to the affected tooth prior to the session.
* These pain levels will be recorded using the Visual Analog Scale (VAS).

Group Allocation:

* After rubber dam isolation and access cavity preparation, patients will be randomly assigned to one of four groups using a four-sided die.
* Each group will consist of 22 patients and will undergo root canal shaping using an endomotor with one of the following techniques:

  1. Continuous Rotation
  2. Apical Reverse
  3. Apical Slow-Down

Questionnaire:

Patients will be given a pen and will be asked to mark the current and percussion-provoked pain of the related tooth by a numbered linear Visual Analog Scale (VAS) before treatment on Day 0 and Day 3.

Root Canal Shaping:

1. Working Length Determination: Establish the working length and create a glide path using a #10 K-file.
2. Instrumentation Sequence: Enlarge the canals sequentially using rotary files of sizes 15.04, 20.04, 25.06, 30.06, and 35.06.
3. Irrigation: Use 2 ml of 2.5% sodium hypochlorite (NaOCl) for irrigation after each file change.

Sample Collection (First Session):

* After completing the first session:
* Rinse the canals with distilled water.
* Remove remaining liquid with #45 paper points.
* Insert sterile #20.02 paper points into the canals and leave them for 30 seconds to collect periapical exudates.
* Collect three samples per canal. Cut the apical 5 mm of the paper points and place them in 1.5 ml Eppendorf tubes for storage at -80°C.
* The canals will then be rinsed again with 2.5% NaOCl. Patients will be dismissed without using intra-canal medication and instructed to return for the filling session after three days. Patients will be advised to take 800 mg ibuprofen if they experience pain. The medication use will be documented.

Second Session:

* The questionnaire will be held again with the VAS scores and percussion sensivity.

  * After local anesthesia the intermediate restorative material is removed and root canal irrigation with distilled water.
  * Working length is confirmed again with a file. Collect three additional samples per canal using #20.02 paper points as in the first session.
  * Proceed to finalize the root canal treatment.

Final Root Canal Treatment:

1. Perform the final irrigation using 2.5% sodium hypochlorite and 17% EDTA.
2. Fit gutta-percha cones. 35.06 cone or fitting .02 tapered cones will be selected as the master cone according to the anatomy and fit.
3. Fill the canals using a resin-based root canal sealer with lateral condensation utilizing #25 spreader and accessory #20.02 gutta-percha cones.
4. After cutting the excess gutta-percha, clean the cavity and complete the treatment with composite resin restoration.

Sample Handling:

* All collected samples will be stored in a -80°C freezer for biochemical analysis. The analysis will be based on ELISA tests which will investigate the Substance P, IL-1ß, TNF alpha and IL-6 on Day 0 and Day 3.

Post-Treatment:

* The occlusion will be checked using articulation paper, and adjustments will be made if primary contact is present to ensure no traumatic occlusion.

This standardized protocol ensures consistent data collection and optimal treatment outcomes for all participants.

Eligibility criteria: Inclusion Criteria:

* Mild, moderate pulpitis and pulpal expose patients in need of root canal -treatment to their mandibular premolars.
* Healthy periodontal tissue with Periapical Index under 2.
* Helathy adjacent teeth.

Exclusion Criteria:

* Systemic diseases
* Percussion pain
* Patients who did not consent to a vital pulp therapy
* Radiologically seen open apex, root resorption, calcification
* Periodontal pocket beyond 4mm in length
* Consumption of Antibiotics or Corticosteroids 1 month before the treatment
* Consumption of antiinflammatory drugs 2 days before the treatment

Primary outcomes:
measure: Substance P
timeFrame: From Day 0 to Day 3. The last measurement will be taken just before the end of the interventional treatment.
Secondary outcomes:
measure: Visual Analog Scale
timeFrame: From Day 0 to Day 3. The last measurement will be taken just before the end of the interventional treatment.
measure: Inflammatory Mediator: IL-1ß
timeFrame: From Day 0 to Day 3. The last measurement will be taken just before the end of the interventional treatment.
measure: Inflammatory Mediator: IL-6
timeFrame: From Day 0 to Day 3. The last measurement will be taken just before the end of the interventional treatment.
measure: Inflammatory Mediator: TNF alpha
timeFrame: From Day 0 to Day 3. The last measurement will be taken just before the end of the interventional treatment.
Other outcomes:
Locations:
city: İzmir
country: Turkey
facility: İzmir Katip Çelebi Üniversitesi
state: Çiğli
Study officials:
affiliation: İzmir Katip Çelebi Üniversitesi
name: Emrah Karataşlıoğlu, PhD
role: STUDY_CHAIR
affiliation: İzmir Katip Çelebi Üniversitesi
name: Mustafa Mert Tulgar, Dmd
role: PRINCIPAL_INVESTIGATOR
affiliation: İzmir Katip Çelebi Üniversitesi
name: Yağmur Kılıç, Dmd
role: PRINCIPAL_INVESTIGATOR
References:
citation: Cohen, J (1988) Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum